MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2024-09-30, SYRS made $6,670K in revenue. -$6,396K in net income. Net profit margin of -95.89%.

Income Overview

Revenue
$6,670K
Net Income
-$6,396K
Net Profit Margin
-95.89%
EPS
-$0.16
Unit: Thousand (K) dollars
Revenue Breakdown
    • Research and development expense...
    • Fair value adjustment of warrant...
    • General and administrative expen...
    • Interest income

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2024-09-30
General and administrative expense, total
5,655
Research and development expense, total
20,527
Total operating expenses
26,182
Loss from operations
-26,182
Fair value adjustment of warrants
-20,305
Interest expense
1,312
Interest income
793
Net loss applicable to common stockholders
-6,396
Basic eps
-0.16
Diluted eps
-0.16
Basic average shares
39,335,772
Diluted average shares
39,335,772
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss applicableto common...-$6,396K Interest income$793K Fair valueadjustment of warrants-$20,305K Interest expense$1,312K Loss from operations-$26,182K Total operatingexpenses$26,182K Research and developmentexpense, total$20,527K General andadministrative expense, total$5,655K

Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals, Inc. (SYRS)